StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pacira Pharmaceuticals (PCRX) PT Raised to $60 at RBC Capital
November 2, 2018 7:14 AM
RBC Capital analyst Randall Stanicky ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Pacira Pharmaceuticals (PCRX) PT Raised to $46 at Mizuho Securities Following 3Q
November 5, 2018 7:16 AM
Pacira Pharmaceuticals (PCRX) PT Raised to $63 at JMP Securities
November 1, 2018 4:12 PM
Pacira Pharmaceuticals (PCRX) PT Raised to $60 at Needham & Company
November 1, 2018 3:49 PM
Pacira Pharmaceuticals (PCRX) PT Raised to $55 at Piper Jaffray
November 1, 2018 1:13 PM
Form 10-Q Pacira Pharmaceuticals, For: Sep 30
November 1, 2018 12:18 PM
UPDATE: Pacira Pharma (PCRX) Tops Q3 EPS by 23c, Revenues Beat; Boosts FY18 Revenue Outlook
November 1, 2018 8:13 AM
Pacira Pharmaceuticals, Inc. Reports Third Quarter 2018 Financial Results
November 1, 2018 8:00 AM
